Roland Andersson & Thomas Krohn: Transcelerate BioPharma Initiative
In this 4-minute audio snippet, Roland Andersson, Director for Accenture's Life Sciences R&D practice, and Thomas Krohn, Director, Clinical Open Innovation, Eli Lilly, discuss the Transcelerate Biopharma initiative, the goals of which are to increase compliance and the productivity of clinical trials.
Tom Stossel: Debunking the “Conflict-of-Interest Narrative”
In this 5-minute audio snippet, Thomas P. Stossel, M.D., visiting scholar at the American Enterprise Institute for Public Policy Research, talks about what he calls the 'Conflict-of-Interest Narrative' or Myth, which is the subject of his new book, PharmaPhobia.
Todd D. Clark: What Can Pharma Do to Avoid the Slow-Growth Trap?
In this 3-minute audio snippet, Todd D. Clark, President of Value of Insight Consulting and the author of pharmahandbook and generichandbook, discusses a few ideas on how the pharmaceutical industry can avoid the slow-growth trap in the U.S. market.
Bradley Merrill Thompson: Coming Soon: FDA Guidance on Regulation of Clinical Decision Support (CDS)...
Bradley Merrill Thompson, Member of the Firm at Epstein Becker & Green and General Counsel to the mHealth Regulatory Coalition, warns of FDA mobile guidance that the drug industry should be concerned about: new guidelines regarding FDA's regulation of clinical decision support (CDS) software.
Len Starnes: The Emerging Virtual Medical Conference
In this 2.5-minute audio snippet, Len Starnes, a renowned digital healthcare consultant, talks about the transformation of medical congresses from the physical to the virtual. Starnes touches on the challenges and gives an example of how one medical society is overcoming them.
Silja Chouquet: Appropriate Use of Twitter by Pharma
In this 2-minute audio snippet, Silja Chouquet, Owner at whydot GmbH, suggests that pharmaceutical companies should stop trying to market brands via Twitter and focus on using it to support patients.
A Shower of Oxycodone in West Virginia, a Flood of Drug Adverse Event Reports...
In this 4.5-minute audio snippet, Pharmaguy discusses how West Virginia and other rural areas are being showered with opioids by drug companies, which could be a major cause in the current flood of drug adverse events.
Alan Schwarz and Dr. Aaron Kesselheim: The Selling of ADHD and Ethics of Disease...
In this 1-minute audio snippet, Alan Schwarz, National Correspondent at The New York Times and Dr. Aaron Kesselheim, Assistant Professor of Medicine, Brigham and Women's Hospital, discuss the ethics of disease awareness ads -- specifically ADHD awareness ads -- that mention the benefits of a class of drugs without also mentioning the common risks.
Senator Bernie Sanders: Why Can FDA Allow Importation of Fish But Not Rx Drugs?
In this 1.5-minute audio snippet, Senator Bernie Sanders blasts FDA Commissioner nominee Robert Califf about drug reimportation of FDA-approved Rx Drugs and high drug prices.
Rob Helper: The Market Research Benefits of Social Video
In this 2.5-minute audio snippet, Rob Halper, former Director, Corporate Communications and Video Communication, at Johnson & Johnson, talks about the benefits of truly social video. In particular, socially-enabled Youtube videos can be valuable market research tools.









